Benjamin Amoah1, Claudio Fronterre1, Olatunji Johnson1, Michael Dejene2, Fikre Seife3, Nebiyu Negussu4, Ana Bakhtiari5, Emma M Harding-Esch6, Emanuele Giorgi1, Anthony W Solomon7, Peter J Diggle1. 1. Centre for Health Informatics, Computing and Statistics, Lancaster Medical School, Lancaster University, Bailrigg, Lancaster, UK. 2. Michael Dejene Public Health Consultancy Services, Addis Ababa, Ethiopia. 3. Disease Prevention and Control Directorate, Federal Ministry of Health, Addis Ababa, Ethiopia. 4. Children's Investment Fund Foundation, London, UK. 5. International Trachoma Initiative, Task Force for Global Health, Decatur, GA, USA. 6. Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK. 7. Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.
At the very low prevalence required to meet thresholds defining elimination
as a public health problem for some neglected tropical diseases,
traditional statistical methods of estimating prevalence yield imprecise
estimates.Model-based geostatistics (MBG) borrows strength of information across different
sampled locations to an extent determined by the strength of the estimated spatial
correlation between locations.In our study, the MBG approach delivered trachomatous trichiasis prevalence estimates
that were, on average, 10 times more precise than those given by the traditional
approach to estimating trachomatous trichiasis prevalence; allowed assessment of
elimination status to be made with greatly reduced uncertainty for a given sample
size; and enabled estimation of disease prevalence in unsampled evaluations units
sufficiently close to sampled locations.If cost considerations are paramount, MBG allows elimination surveys to be designed
with substantially fewer sampled locations than the traditional approach while
achieving the same, or better, precision.
Introduction
Neglected tropical diseases rank among the world’s greatest global health problems because
of their substantial contribution to global morbidity, disability and mortality. The highest
burdens of neglected tropical diseases occur in the tropical and subtropical regions of the
world, affecting the world’s poorest people and exacerbating poverty through their
detrimental effects on work productivity, child development and women’s health., In the London Declaration, 22 partners including
endemic countries, non-governmental organizations, pharmaceutical companies and donors
committed to controlling, eliminating or eradicating at least 10 neglected tropical diseases
by the year 2020. Experts in
neglected tropical diseases are generally optimistic about the prospects of elimination for
lymphatic filariasis, onchocerciasis and trachoma, although the dates by which success could be anticipated have
recently been revised.For selected neglected tropical diseases, elimination as a public health
problem is defined as the reduction of prevalence in a given geographic area to a
disease-specific level set by the World Health Organization (WHO). Determining the elimination status of an at-risk
population is of critical importance, but complete ascertainment of disease or reinfection
status for every member of an at-risk population is impractical. Therefore, it is imperative
that prevalence surveys are designed, and the resulting data analysed, using the most
efficient statistical methods. In this study, we used extensive prevalence survey data on
trachoma in Ethiopia to demonstrate how the application of model-based geostatistical
analysis can achieve very substantial gains in precision over the traditional statistical
analysis methods that are currently used in this context.Trachoma is the leading infectious cause of blindness globally., The disease is caused by repeated infection of the conjunctiva
with particular strains of the bacterium Chlamydia trachomatis. Higher forces of infection are
associated with poor facial cleanliness, overcrowding, absence of functional latrines and
overall poor community-level sanitation.
Infection often results in conjunctival inflammation with follicles (‘active trachoma’) that
may meet the WHO’s definition of the sign ‘trachomatous inflammation–follicular’ (TF). TF prevalence is highest in young
children, who also harbour the highest bacterial loads., In
individuals with repeated reinfections, scarring of the conjunctivae with consequent
in-turning of the eyelashes can occur. This is called trachomatous trichiasis. The in-turned eyelashes cause pain at each blink and may, over
time, cause scarring of the cornea, leading to visual impairment and blindness.,Elimination of trachoma as a public health problem is defined as (i) a prevalence of
trachomatous trichiasis unknown to the health system of <0.002 (0.2%) in adults aged
≥15 years and (ii) a prevalence of TF <0.05 (5%) in children aged 1–9 years, in each
formerly endemic evaluation unit; plus (iii) the presence of a system to identify and manage
incident cases of trachomatous trichiasis, which are expected to arise for many years after
the prevalence thresholds (i) and (ii) are met. An evaluation unit for assessing elimination
is defined as the normal administrative unit for healthcare management, which typically
contains a population of between 100 000 and 250 000 people.To achieve these endpoints, the WHO Alliance for the Global Elimination of Trachoma by 2020
recommends use of the SAFE strategy of Surgery to correct trachomatous trichiasis,
antibiotics to clear C. trachomatis infection, and facial cleanliness and
environmental improvement to reduce transmission. Ethiopia has been the country with the
highest levels of trachoma prevalence, and has implemented the SAFE strategy to push towards trachoma
elimination.Several factors have impeded the prospects of trachoma elimination. First, it has been
challenging to control the recrudescence of infection after mass drug administration with
azithromycin, the preferred antibiotic for active trachoma treatment. Reinfection has
occurred repeatedly even under high mass drug-administration coverage. The outbreak of the COVID-19 pandemic and the
subsequent suspension of some control activities are likely to facilitate a faster
resurgence. Second, there has been a high recurrence rate of trichiasis after surgical
correction. Third, even after
no infections can be detected at the population level, inflammation in children’s
conjunctivae may continue to occur. Fourth, the relationship between environmental factors and trachoma
are poorly understood and, in some areas, environmental corrections have failed to yield the
expected impact. More research
in these areas is needed to better understand how the SAFE strategy could be optimized to
enhance the chances of trachoma elimination.A critical challenge in trachoma elimination is establishing the prevalence of the disease
in elimination settings, and hence determining whether or not elimination has been achieved.
At the very low prevalence levels required to meet elimination thresholds, prevalence
estimates are typically very imprecise. Two sources of imprecision exist. First, estimates
are sure to be imprecise if the entire population at risk is not tested using the perfect
diagnostic tool in a perfect manner. Second, imprecision arises from the sampling design
used to collect the data, and the statistical methods and models used to analyse them. As
prevalence decreases and the disease becomes rare, increasingly large sample sizes are
needed to estimate the prevalence of the disease to a high level of precision, which is
needed to increase the chances of making the correct decision on whether or not elimination
has been achieved and avoiding inconclusive results.The 3rd Global Scientific Meeting on Trachoma, in an attempt to solve the problem of
imprecise estimates, stipulated the use of population-based prevalence surveys through
cluster random sampling powered to detect a TF prevalence of 4% with the absolute precision
of ±2% at the evaluation-unit level, which would require an estimated 970 children aged
1–9 years per survey.Meanwhile, to estimate with 95% confidence an expected trachomatous trichiasis prevalence
of 0.2% with an absolute precision of ±0.2% would require an estimated 2818 adults aged
≥15 years or data from 30 first-stage clusters. However, the challenge is that many impact
and surveillance surveys are primarily designed to estimate the prevalence of TF in 1– to
9-year-olds and result in <30 first-stage clusters and <2818 adults aged
≥15 years. Against this
background, we applied geospatial methods to improve the precision of trachomatous
trichiasis prevalence estimates using data from impact and surveillance surveys conducted in
Ethiopia, despite their apparent lack of power.Environmental and some socio-economic factors are correlated in space, and so are the
diseases that depend on them. When a disease is spatially correlated, its prevalence at a
geographical location informs the prevalence at other locations, with the strength of the
correlation increasing with decreasing distance apart. The current method of estimating
trachomatous trichiasis prevalence does not include spatial correlation in estimating the
risk of infection within or between evaluation units, thus implicitly assuming that data
from different geographical locations are independent. However, when substantial spatial
correlation exists in the data, accounting for it and exploiting it in a model-based
geostatistics (MBG) framework have several advantages. First, inferences on estimated
regression relationships are more reliable because the data analysis accounts for additional
unexplained variability in the data. Second, there are substantial improvements in the
precision of prevalence estimates because the information provided by the spatial
correlation reduces the uncertainty in the data. Third, the estimated spatial correlation
allows predictions at unsampled geolocations that are close enough to sampled geolocations.
The aim of this paper was to apply MBG to impact and surveillance survey data from Ethiopia
to determine whether this approach enables more precise trachomatous trichiasis prevalence
estimates to be obtained.
Methods
Sampling and data
To determine whether the elimination prevalence target for trachomatous trichiasis has
been reached in formerly endemic evaluation units, acceptable approaches are: (i)
population-based prevalence surveys powered at the evaluation-unit level (i.e. ‘the normal
administrative unit for healthcare management, consisting of a population unit of
100 000–250 000 persons’); (ii) house-to-house case searches (which could be integrated
with other public health activities); or (iii) a combination of data from multiple
adjacent evaluation units.We used existing data from trachoma impact and surveillance surveys powered at the
evaluation-unit level, conducted in 2017, 2018 and 2019 in the following Ethiopian
regions: Tigray; Oromia; Amhara; Gambella; Benishangul-Gumuz; Southern Nations,
Nationalities, and Peoples’ Region. All the surveys were conducted with Tropical Data
support, which uses the same standardized, robust methodology as used in the Global
Trachoma Mapping Project.Impact and surveillance surveys were conducted according to the schedule recommended by
the WHO. Impact surveys were
carried out in evaluation units ≥6 months after completion of the WHO-recommended numbers
of rounds of annual antibiotic mass drug administration. Surveillance surveys were carried
out in evaluation units that had achieved the WHO TF elimination threshold of 0.05 among
children aged 1–9 years, measured at impact surveys, and had then stopped mass antibiotic
administration for ≥2 years before being resurveyed.The design for both an impact and a surveillance survey conformed with the WHO
recommendations and included
the following basic elements. First, in each evaluation unit, 20–30 villages were selected
using a probability-proportional-to-population-size method. Second, within each selected
village, a group of 30 households was selected using compact segment sampling. Finally,
every resident aged ≥1 year in each selected household was invited to participate.,, Both eyes of consenting residents were examined
for trachomatous trichiasis and TF using the WHO’s simplified grading system for
trachoma. For our analysis,
we considered a case of trachomatous trichiasis to be anyone aged ≥15 years with at least
one eyelash from the upper or lower eyelid touching the eyeball, or evidence of recent
epilation of in-turned eyelashes from the upper or lower eyelid.
Estimating evaluation-unit-level prevalence
The prevalence of trachomatous trichiasis is higher in females and increases with
age. However, daytime population-based surveys are likely to
over-represent older individuals and females. The data analysis therefore needs to adjust
for age and gender so that predictions correctly reflect the demography of the population.
We binned age in 5-year bands from 15 to 69 years and a single band for ≥70 years.
Traditional approach
In our implementation of the traditional approach to estimation of population-based
trachomatous trichiasis prevalence from cluster-level proportions, we adjusted for age and
gender using the 2007 Ethiopia census data as the standard population. We then developed
95% confidence intervals by bootstrapping adjusted cluster-level proportions over 10 000
replicates. For districts with no sampled cases, we estimated upper confidence interval
limits as one-sided 97.5% exact binomial confidence intervals.
Geostatistical approach
Our geostatistical model was a logistic regression with the addition of two kinds of
random effects: spatially correlated residual variation, which we modelled using a
stationary Gaussian process; and spatially uncorrelated residual variation, which we
modelled as Gaussian noise.A symbolic description of the model is where α is the regression
parameter for the survey year (2017, 2018 or 2019) and β is
the regression parameter for the age–gender class of the individual. Informally, the
right-hand side of Equation (1) divides the
variation in the log-odds of prevalence into an explained component (here, year of survey
and age–gender class) and an unexplained component (here, partitioned into spatially
correlated and spatially uncorrelated subcomponents, in proportions to be determined by
the data). Technical details of the model and model building process are given in the
Supplementary Appendix
(available as Supplementary data
at IJE online).To estimate local trachomatous trichiasis prevalence, we placed a 5 × 5 km grid on the
study region. Within each grid-cell, we then estimated trachomatous trichiasis prevalence
for each age–gender class and computed the class-weighted prevalence, where the weights
were the proportions of the population in each class according to the 2007 census of
Ethiopia.Our geostatistical evaluation-unit-level predictions needed to account for the
within-evaluation-unit heterogeneity in population density. We used the class-weighted
trachomatous trichiasis prevalence from all grid-cells within an evaluation unit to
estimate evaluation-unit-wide prevalence as a population-weighted prevalence,
incorporating estimated population counts from WorldPop.We obtained 10 000 predictive samples for each evaluation unit and from these computed
the following quantities: the evaluation-unit-wide prevalence was the
mean of the predictive samples of prevalence for that evaluation unit; the associated
95% prediction interval was the range from the 2.5th to 97.5th
percentiles; the probability of elimination was the proportion of
predictive samples less than the elimination threshold.The Supplementary Appendix
(available as Supplementary data
at IJE online) gives technical details of the modelling, model-fitting,
prediction algorithm and model-validation.
Results
We collected data from 458 678 individuals (268 297 females and 190 381 males) sampled
from 7447 clusters. Figure 1 shows the
locations of all clusters, colour-coded according to their empirical prevalences. The
overall empirical prevalence was 0.021 with interquartile range 0.000–0.032.
Figure 1
Cluster locations colour-coded according to their year of survey
Cluster locations colour-coded according to their year of survey
Model estimates
The estimates of the log-odds of trachomatous trichiasis prevalence in the age–gender
classes (Figure 2) show, as expected,, that trachomatous trichiasis prevalence is higher
in females and increases with age. The higher trachomatous trichiasis prevalence in women
has been attributed to their propensity to spend more time than men caring for
children, who constitute the
highest prevalence group and harbour the highest parasite loads.
Figure 2
Point estimates of the log-odds of prevalence in the age–gender classes and
associated 95% confidence intervals
Point estimates of the log-odds of prevalence in the age–gender classes and
associated 95% confidence intervalsThe estimates of the log-odds of trachomatous trichiasis prevalence in different years
(Figure 3) show subtle differences and the
three 95% confidence intervals largely overlap.
Figure 3
Point estimates of the log-odds of prevalence in different years and associated 95%
confidence intervals
Point estimates of the log-odds of prevalence in different years and associated 95%
confidence intervalsFigure 4 shows the structure of the estimated
residual spatial correlation in the form of a variogram. A rising trend indicates the
presence of spatial variation.
Figure 4
Estimates of the residual spatial correlation structure (solid line) and its 95%
confidence region (grey area)
Estimates of the residual spatial correlation structure (solid line) and its 95%
confidence region (grey area)
Prediction of prevalence and probability of elimination
Figure 5 shows the predicted trachomatous
trichiasis prevalences at the evaluation-unit level. Predicted prevalences were less than
the elimination threshold of 0.002 in nine evaluation units. These evaluation units and
their respective predicted prevalences are: Ale, 0.0019; Arbe Gona, 0.0013; Aroresa,
0.0016; Bensa, 0.0014; Bore, 0.0017; Dara, 0.0018; Hulla, 0.0013; Kokosa, 0.0018; and
Metu, 0.0019. Summary statistics of the distribution of predicted prevalences over all
evaluation units are: Minimum = 0.00130; 1st Quartile = 0.0030; Median = 0.0077;
Mean = 0.0090; 3rd Quartile = 0.0114; Maximum = 0.0353.
Figure 5
Map of the predicted prevalence for the evaluation units
Map of the predicted prevalence for the evaluation unitsFigure 6 shows the probability, for each
evaluation unit, that trachomatous trichiasis prevalence is below the elimination
threshold of 0.002. This probability is close to zero in most evaluation units. Eight of
the 482 evaluation units met the elimination criteria, with a probability of ≥0.9. These
evaluation units are those with a predicted prevalence of <0.002, with the exception of
Ale. Conversely, with a probability of ≥0.9, 469 evaluation units have
not achieved the elimination threshold. One evaluation unit (Wenago)
has achieved elimination with a probability of 0.88. For all remaining evaluation units,
the probability of elimination lies between 0.45 and 0.65.
Figure 6
Map of the probability of elimination, given an elimination threshold of 0.002 of TT
Map of the probability of elimination, given an elimination threshold of 0.002 of TTDetailed predictions (prevalence, 95% confidence interval and probability of elimination)
for all 482 evaluation units are given in Supplementary Table S1 (available as Supplementary data at
IJE online).
Comparison of the traditional approach with the geostatistical approach
For each of the 257 evaluation units that contain sampled clusters, we used the
traditional approach to estimate prevalence and its associated 95% confidence interval. We
then compared these estimates with those of the geostatistical approach by calculating the
difference between the traditional and geostatistical prevalence estimates and the ratio
of the length of the traditional 95% confidence interval to the 95% geostatistical
prediction interval. The differences between prevalences across the 257
evaluation units can be described by the following summary statistics: Minimum = 0.0000;
1st Quartile = 0.0018; Median = 0.0048; Mean = 0.0066; 3rd Quartile = 0.0086;
Maximum = 0.1048. Judged relative to the elimination threshold of 0.002, these are not
negligible differences. Summary statistics for the ratio of the traditional to the
geostatistical 95% intervals are: Minimum = 3.5; 1st Quartile = 7.9; Median = 9.9;
Mean = 17.2; 3rd Quartile = 14.9; Maximum = 146.7. This represents a dramatic improvement
in efficiency. Results for each evaluation unit are given in Supplementary Table S2 (available as
Supplementary data at
IJE online).We did not find appreciable differences in the prevalence of trachomatous trichiasis over
the years 2017, 2018 and 2019. This suggests that, notwithstanding progress to date,
Ethiopia may need more intensive interventions to achieve nationwide elimination.
Discussion
We mapped the evaluation-unit-level prevalence of trachomatous trichiasis in Ethiopia and
the probability that the prevalence is less than the elimination threshold of 0.002 (0.2%).
We then illustrated the gains in precision of prevalence estimates achieved by applying
geostatistical methods of estimation over the traditional approach by comparing the
respective lengths of the 95% predictive intervals of evaluation-unit-level prevalence.
Through Monte Carlo methods, we showed that there is a considerable spatial correlation in
trachomatous trichiasis risk in Ethiopia and that exploiting this information in an MBG
framework leads to substantial improvements in the precision of trachomatous trichiasis
prevalence estimates at the evaluation-unit level.In November 2018, the 4th Global Scientific Meeting on Trachoma agreed that national
programmes could use a combination of data from multiple adjacent evaluation units to assess
whether the elimination prevalence target for trachomatous trichiasis has been reached. This presupposes that trachomatous
trichiasis prevalence in an evaluation unit can be, to some extent, informed by trachomatous
trichiasis prevalence in adjacent evaluation units, or that decision-makers would accept
trachomatous trichiasis prevalence estimates calculated for larger population units.
Estimates based on the pooling of data over multiple evaluation units leads to reduced
variance, but at the risk of introducing bias. This immediately raises the question: Over
what geographical scale can data legitimately be pooled? One strength of the geostatistical approach is that
it allows the data to answer the question rather than imposing an arbitrary, predefined
rule. Our model-based geostatistical framework assumes that, after adjusting for relevant
covariates, the residual component of variation in prevalence is spatially correlated, but
allows the data to determine the strength and spatial scale of this phenomenon.The current conventional approach to assess whether the trachomatous trichiasis elimination
threshold has been met is through calculating a point estimate of prevalence with an
attached confidence interval. We have shown through the Ethiopian trachomatous trichiasis
case study that the resulting confidence intervals can be an order of magnitude wider than
the corresponding geostatistical prediction intervals. This dramatic improvement in
efficiency from using a geostatistical approach stems from two quite different
considerations. First, the geostatistical approach in effect chooses the optimal pooling of
data from spatially neighbouring locations to construct a spatially continuous surface of
predicted prevalences that can then be aggregated to whatever set of geographical units is
relevant for public health decision-making in context. Second, it answers the right
question. The confidence intervals used in the conventional approach measure the
uncertainty with which prevalence can be estimated over a hypothetical universe of repeated
realizations of the disease process. Geostatistical prediction intervals measure the
uncertainty for the particular realization of the disease process that has actually
occurred.Another advantage of applying MBG in this context is that it allowed us to quantify
uncertainty by using exceedance probabilities, which we argue directly answer the
policymakers’ question of whether or not elimination has been achieved, rather than relying
on point estimates and confidence intervals that are difficult to interpret in relation to
the policy-relevant question and consequently the chances of right/wrong decisions.
Importantly, it reports for each evaluation unit the probability that
elimination has been achieved, thereby forcing consideration of the uncertainty that is
necessarily attached to any declaration that elimination has or has not been achieved.Impact and surveillance surveys do not have the primary power to estimate trachomatous
trichiasis prevalence using the traditional approach unless they meet the requirement of
trachomatous trichiasis-only surveys, namely a sample size of 2818 adults or 30 clusters
within an evaluation unit. A
strength of the geostatistical analysis is that more precise trachomatous trichiasis
prevalence estimates can be calculated from trachoma impact and surveillance prevalence
surveys by borrowing the strength of information across space. The geostatistical approach
therefore enables increased precision for less field-sampling effort.Our geostatistical model (1) for the Ethiopia trachomatous trichiasis data included
adjustments for year and for the varying demography of different evaluation units. It would
be straightforward to extend the model to accommodate other forms of covariate information
that can be made available throughout the area over which predictions are required, e.g.
raster images of environmental variables.The geostatistical approach is disease-agnostic. Its application to other neglected
tropical diseases may involve including covariate information or incorporating established
disease-specific knowledge to inform the specification of the residual spatial correlation
structure. For an application to the design of elimination surveys for lymphatic filariasis
in Ghana, see Fronterre et al.A perfect estimation of evaluation-unit-level prevalence would require adjusting for
spatial heterogeneities in population size using high-quality, timely census data, available
at every prediction geographical location. However, census data for Ethiopia are available
as aggregated counts at the regional (admin two) level and not at fine spatial scales.
Therefore, to account for spatial heterogeneities in population counts, we used population
counts raster data from WorldPop. These data are modelled and are therefore a limitation of
our analysis. A drawback of using these data is that in countries that have not had a census
for a long time and where substantial subnational variations in migration, fertility and
mortality exist, the WorldPop data can be highly uncertain. If estimates of possible
uncertainties in these data were available, we could adjust for them by drawing sample
population surfaces and recomputing evaluation-unit-level prevalence for each draw. By
repeating this process a sufficiently large number of times, summaries of
evaluation-unit-level prevalence would have considered possible uncertainties in the
population estimates.
Conclusions
The trachomatous trichiasis criterion for the elimination of trachoma as a public health
problem, as defined by trachomatous trichiasis prevalence <0.002 in ≥15-year-olds, has
not been widely achieved in Ethiopia. By exploiting residual spatial correlation in
trachomatous trichiasis prevalence within an MBG framework, we obtained estimates of
trachomatous trichiasis prevalence that are, on average, 10 times as precise as those
obtained from the currently used approach. Geostatistical methods therefore present
opportunities for sharper and more affordable sampling strategies to inform decisions on the
elimination of trachoma and other neglected tropical diseases.
Supplementary data
Supplementary data are available
at IJE online.
Ethics approval
Ethical clearance for the study was granted by the Lancaster University’s Faculty of Health
and Medicine Research Ethics Committee (FHMREC21005).
Funding
The authors acknowledge funding of the neglected tropical disease Modelling Consortium by
the Bill and Melinda Gates Foundation [OPP1184344]. A.W.S. is a staff member of the World
Health Organization.
Disclaimer
The authors alone are responsible for the views expressed in this article and they do not
necessarily represent the views, decisions or policies of the institutions with which they
are affiliated. The boundaries and names shown and the designations used on the maps in this
article do not imply the expression of any opinion whatsoever on the part of the authors, or
the institutions with which they are affiliated, concerning the legal status of any country,
territory, city or area or of its authorities, or concerning the delimitation of its
frontiers or boundaries.
Data availability
The data underlying this article were provided by the Federal Ministry of Health of
Ethiopia (FMOH), with permission. Data will be shared on reasonable request to Fikre Seife,
fikre-seife5@gmail.com, with the permission of the FMOH.
Author contributions
A.W.S. and P.J.D. conceived of the project. All authors contributed to the formulation of
overarching research goals and aims. B.A., E.G. and P.J.D. developed the geostatistical
model and carried out the statistical analyses. B.A., C.F., O.J. and E.G. developed the code
for the statistical analyses and carried out numerical simulations. N.N., F.S., M.D. and
E.H.E. verified the traditional analysis. A.B. carried out data curation. B.A. produced
visualization of the results and wrote the first draft. All authors provided critical
feedback and helped to shape the research, analyses and manuscript.
Conflict of interest
E.H.E. reports grants from the International Trachoma Initiative, Pfizer Inc., during the
conduct of the study. A.B. reports personal fees from Pfizer Inc., outside the submitted
work. For all the other authors, none declared.Click here for additional data file.
Authors: Jeremy D Keenan; Peter J Hotez; Abdou Amza; Nicole E Stoller; Bruce D Gaynor; Travis C Porco; Thomas M Lietman Journal: PLoS Negl Trop Dis Date: 2013-12-05
Authors: William E Oswald; Aisha Ep Stewart; Michael R Kramer; Tekola Endeshaw; Mulat Zerihun; Berhanu Melak; Eshetu Sata; Demelash Gessese; Tesfaye Teferi; Zerihun Tadesse; Birhan Guadie; Jonathan D King; Paul M Emerson; Elizabeth K Callahan; Dana Flanders; Christine L Moe; Thomas F Clasen Journal: Bull World Health Organ Date: 2017-01-26 Impact factor: 9.408
Authors: Christopher J L Murray; Theo Vos; Rafael Lozano; Mohsen Naghavi; Abraham D Flaxman; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Diego Gonzalez-Medina; Richard Gosselin; Rebecca Grainger; Bridget Grant; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Francine Laden; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Daphna Levinson; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Charles Mock; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Natasha Wiebe; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Mohammad A AlMazroa; Ziad A Memish Journal: Lancet Date: 2012-12-15 Impact factor: 79.321
Authors: Rafael Lozano; Mohsen Naghavi; Kyle Foreman; Stephen Lim; Kenji Shibuya; Victor Aboyans; Jerry Abraham; Timothy Adair; Rakesh Aggarwal; Stephanie Y Ahn; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Suzanne Barker-Collo; David H Bartels; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Kavi Bhalla; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; Fiona Blyth; Ian Bolliger; Soufiane Boufous; Chiara Bucello; Michael Burch; Peter Burney; Jonathan Carapetis; Honglei Chen; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Diego De Leo; Louisa Degenhardt; Allyne Delossantos; Julie Denenberg; Don C Des Jarlais; Samath D Dharmaratne; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Patricia J Erwin; Patricia Espindola; Majid Ezzati; Valery Feigin; Abraham D Flaxman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Sherine E Gabriel; Emmanuela Gakidou; Flavio Gaspari; Richard F Gillum; Diego Gonzalez-Medina; Yara A Halasa; Diana Haring; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Bruno Hoen; Peter J Hotez; Damian Hoy; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Ganesan Karthikeyan; Nicholas Kassebaum; Andre Keren; Jon-Paul Khoo; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Michael Lipnick; Steven E Lipshultz; Summer Lockett Ohno; Jacqueline Mabweijano; Michael F MacIntyre; Leslie Mallinger; Lyn March; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; John McGrath; George A Mensah; Tony R Merriman; Catherine Michaud; Matthew Miller; Ted R Miller; Charles Mock; Ana Olga Mocumbi; Ali A Mokdad; Andrew Moran; Kim Mulholland; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Kiumarss Nasseri; Paul Norman; Martin O'Donnell; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; David Phillips; Kelsey Pierce; C Arden Pope; Esteban Porrini; Farshad Pourmalek; Murugesan Raju; Dharani Ranganathan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Frederick P Rivara; Thomas Roberts; Felipe Rodriguez De León; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Joshua A Salomon; Uchechukwu Sampson; Ella Sanman; David C Schwebel; Maria Segui-Gomez; Donald S Shepard; David Singh; Jessica Singleton; Karen Sliwa; Emma Smith; Andrew Steer; Jennifer A Taylor; Bernadette Thomas; Imad M Tleyjeh; Jeffrey A Towbin; Thomas Truelsen; Eduardo A Undurraga; N Venketasubramanian; Lakshmi Vijayakumar; Theo Vos; Gregory R Wagner; Mengru Wang; Wenzhi Wang; Kerrianne Watt; Martin A Weinstock; Robert Weintraub; James D Wilkinson; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Paul Yip; Azadeh Zabetian; Zhi-Jie Zheng; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish Journal: Lancet Date: 2012-12-15 Impact factor: 79.321
Authors: Colin K Macleod; Travis C Porco; Michael Dejene; Oumer Shafi; Biruck Kebede; Nebiyu Negussu; Berhanu Bero; Sadik Taju; Yilikal Adamu; Kassahun Negash; Tesfaye Haileselassie; John Riang; Ahmed Badei; Ana Bakhtiari; Rebecca Willis; Robin L Bailey; Anthony W Solomon Journal: Ophthalmic Epidemiol Date: 2018-12-28 Impact factor: 1.648
Authors: Christine Tedijanto; Solomon Aragie; Zerihun Tadesse; Mahteme Haile; Taye Zeru; Scott D Nash; Dionna M Wittberg; Sarah Gwyn; Diana L Martin; Hugh J W Sturrock; Thomas M Lietman; Jeremy D Keenan; Benjamin F Arnold Journal: PLoS Negl Trop Dis Date: 2022-03-11